308 related articles for article (PubMed ID: 25743833)
1. Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Mansour-Ghanaei F; Joukar F; Mojtahedi K; Sokhanvar H; Askari K; Shafaeizadeh A
Asian Pac J Cancer Prev; 2015; 16(4):1571-4. PubMed ID: 25743833
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.
Ito M; Haruma K; Kamada T; Mihara M; Kim S; Kitadai Y; Sumii M; Tanaka S; Yoshihara M; Chayama K
Aliment Pharmacol Ther; 2002 Aug; 16(8):1449-56. PubMed ID: 12182744
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and precancerous conditions of the stomach: the frequency of infection in a cross-sectional study of 79 consecutive patients with chronic antral gastritis in Yaoundé, Cameroon.
Ankouane F; Noah DN; Enyime FN; Ndjollé CM; Djapa RN; Nonga BN; Njoya O; Ndam EC
Pan Afr Med J; 2015; 20():52. PubMed ID: 26090010
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
5. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
[TBL] [Abstract][Full Text] [Related]
6. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
7. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
8. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
9. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.
Ohkusa T; Fujiki K; Takashimizu I; Kumagai J; Tanizawa T; Eishi Y; Yokoyama T; Watanabe M
Ann Intern Med; 2001 Mar; 134(5):380-6. PubMed ID: 11242498
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
11. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
12. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.
Lu B; Chen MT; Fan YH; Liu Y; Meng LN
World J Gastroenterol; 2005 Nov; 11(41):6518-20. PubMed ID: 16425426
[TBL] [Abstract][Full Text] [Related]
13. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
Kapadia CR
J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
15. High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity.
Morales-Espinosa R; Delgado G; Serrano LR; Castillo E; Santiago CA; Hernández-Castro R; Gonzalez-Pedraza A; Mendez JL; Mundo-Gallardo LF; Manzo-Merino J; Ayala S; Cravioto A
PLoS One; 2020; 15(3):e0230220. PubMed ID: 32163505
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of
Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
[TBL] [Abstract][Full Text] [Related]
17. Risk of gastric cancer in children with Helicobacter pylori infection.
Cam S
Asian Pac J Cancer Prev; 2014; 15(22):9905-8. PubMed ID: 25520126
[TBL] [Abstract][Full Text] [Related]
18. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.
Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
Bosn J Basic Med Sci; 2006 Nov; 6(4):48-53. PubMed ID: 17177650
[TBL] [Abstract][Full Text] [Related]
19. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years.
Hwang YJ; Kim N; Lee HS; Lee JB; Choi YJ; Yoon H; Shin CM; Park YS; Lee DH
Aliment Pharmacol Ther; 2018 Feb; 47(3):380-390. PubMed ID: 29193217
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer.
Farinati F; Valiante F; Germanà B; Della Libera G; Baffa R; Rugge M; Plebani M; Vianello F; Di Mario F; Naccarato R
Eur J Cancer Prev; 1993 Jul; 2(4):321-6. PubMed ID: 8358284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
